Goldman Sachs Trims PT on Hologic (HOLX) After Q1, Keeps 'Buy'
Tweet Send to a FriendGet Alerts HOLX Hot Sheet
Price: $20.16 -1.13%
Rating Summary:
16 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
16 Buy, 6 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade HOLX Now!
Goldman Sachs trimmed its price target on Hologic (NASDAQ: HOLX) from $25 to $24 following in-line Q1 results and below-consensus Q2 guidance after the close but is maintaining a Buy rating.
"We continue to have a bullish long-term outlook on the tomosynthesis cycle, synergy upside from the GPRO acquisition, and the potential for material debt service," the analyst said. "On that basis, we continue to think shares are undervalued and attractive relative to our coverage universe. Having said that, we believe near-term share outperformance will depend on improved revenue growth from a combination of tomo adoption and GPRO product cycles."
Goldman raised FY13 EPS from $1.58 to $1.60, FY14 from $1.90 to $1.94 and FY15 from $2.11 to $2.12.
For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.
Shares of Hologic closed at $23.25 yesterday, with a 52 week range of $16.18-$23.96.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
"We continue to have a bullish long-term outlook on the tomosynthesis cycle, synergy upside from the GPRO acquisition, and the potential for material debt service," the analyst said. "On that basis, we continue to think shares are undervalued and attractive relative to our coverage universe. Having said that, we believe near-term share outperformance will depend on improved revenue growth from a combination of tomo adoption and GPRO product cycles."
Goldman raised FY13 EPS from $1.58 to $1.60, FY14 from $1.90 to $1.94 and FY15 from $2.11 to $2.12.
For an analyst ratings summary and ratings history on Hologic click here. For more ratings news on Hologic click here.
Shares of Hologic closed at $23.25 yesterday, with a 52 week range of $16.18-$23.96.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
- UPDATE: A.G. Lafley Gives Procter & Gamble (PG) Investors 'New Hope', UBS Upgrades to Buy
- Needham & Company Boosts Numbers on Infoblox (BLOX) on Strong Q3
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Goldman Sachs
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
